Here, we show that immunohistochemistry for LC3 and p62 can be used to diagnose drug-induced autophagic vacuolar myopathies, obviating the need for electron microscopy in the great majority of clinically relevant scenarios. The gene discussed is MAP1LC3A; the disease is X-linked myopathy with excessive autophagy.